PD-1highCXCR5-CD4+ Peripheral Helper T (Tph) cells Promote Tissue-Homing Plasmablasts in COVID-19

A dysregulated immune response against coronavirus-2 (SARS-CoV-2) plays a critical role in the outcome of patients with coronavirus disease 2019 (COVID-19). A significant increase in circulating plasmablasts is characteristic of COVID-19 though the underlying mechanisms and its prognostic implications are not known. Here, we demonstrate that in the acute phase of COVID-19, activated PD-1highCXCR5-CD4+ T cells, peripheral helper T cells, (Tph) are significantly increased and promote inflammatory tissue-homing plasmablasts in patients with stable but not severe COVID-19. Analysis of scRNA-seq data revealed that plasmablasts in stable patients express higher levels of tissue-homing receptors including CXCR3. The increased Tph cells exhibited "B cell help" signatures similar to that of circulating T follicular helper (cTfh) cells and promoted B cell differentiation in vitro. Compared with cTfh cells, Tph cells produced more IFN{gamma}, inducing tissue-homing chemokine receptors on plasmablasts. Finally, expansion of activated Tph cells was correlated with the frequency of CXCR3+ plasmablasts in the acute phase of patients with stable disease. Our results demonstrate a novel role for Tph cells in acute viral immunity by inducing ectopic, antibody secreting plasmablasts.

[1]  D. Hafler,et al.  Type I Interferon Transcriptional Network Regulates Expression of Coinhibitory Receptors in Human T cells , 2022, Nature immunology.

[2]  M. C. Muenker,et al.  Kinetics of antibody responses dictate COVID-19 outcome , 2020, medRxiv.

[3]  W. Lau,et al.  Post-infectious inflammatory disease in MIS-C features elevated cytotoxicity signatures and autoreactivity that correlates with severity , 2020, medRxiv.

[4]  M. Shlomchik,et al.  Germinal Center and Extrafollicular B Cell Responses in Vaccination, Immunity, and Autoimmunity. , 2020, Immunity.

[5]  R. Alon,et al.  Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19 , 2020, Nature reviews. Immunology.

[6]  R. Valenta,et al.  Immunological imprint of COVID‐19 on human peripheral blood leukocyte populations , 2020, Allergy.

[7]  William T. Hu,et al.  Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19 , 2020, Nature Immunology.

[8]  Yong Liu,et al.  A comprehensive, longitudinal analysis of humoral responses specific to four recombinant antigens of SARS-CoV-2 in severe and non-severe COVID-19 patients , 2020, PLoS pathogens.

[9]  H. Ueno,et al.  Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases , 2020, Cellular & Molecular Immunology.

[10]  S. Farhadian,et al.  Sex differences in immune responses that underlie COVID-19 disease outcomes , 2020, Nature.

[11]  Kelsey K. Finn,et al.  Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19 , 2020, Cell.

[12]  Jiyuan Zhang,et al.  Single-cell landscape of immunological responses in patients with COVID-19 , 2020, Nature Immunology.

[13]  Elizabeth B White,et al.  Longitudinal analyses reveal immunological misfiring in severe COVID-19 , 2020, Nature.

[14]  Eric Song,et al.  Longitudinal analyses reveal immunological misfiring in severe COVID-19 , 2020, Nature.

[15]  Nichollas E. Scott,et al.  Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 , 2020, Nature Medicine.

[16]  Howard Y. Chang,et al.  Human B cell clonal expansion and convergent antibody responses to SARS CoV-2 , 2020, bioRxiv.

[17]  Lisa E. Wagar,et al.  An Integrated Multi-omic Single-Cell Atlas of Human B Cell Identity , 2020, Immunity.

[18]  Sasikanth Manne,et al.  Deep immune profiling of COVID-19 patients reveals patient heterogeneity and distinct immunotypes with implications for therapeutic interventions , 2020, bioRxiv.

[19]  Lin Cheng,et al.  Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 , 2020, Nature Medicine.

[20]  M. Netea,et al.  Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure , 2020, Cell Host & Microbe.

[21]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[22]  G. Gao,et al.  A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.

[23]  J. Langhorne,et al.  B‐cell memory in malaria: Myths and realities , 2019, Immunological reviews.

[24]  V. Greiff,et al.  Discrete populations of isotype-switched memory B lymphocytes are maintained in murine spleen and bone marrow , 2019, bioRxiv.

[25]  Scott A. Jenks,et al.  Challenges and Opportunities for Consistent Classification of Human B Cell and Plasma Cell Populations , 2019, Front. Immunol..

[26]  A. V. Bocharnikov,et al.  PD-1hi CXCR5- T peripheral helper cells promote B cells responses in lupus via MAF and IL-21. , 2019, JCI insight.

[27]  H. Ljunggren,et al.  NK cells are activated and primed for skin-homing during acute dengue virus infection in humans , 2019, Nature Communications.

[28]  Charles C. Kim,et al.  FCRL5+ Memory B Cells Exhibit Robust Recall Responses , 2019, Cell reports.

[29]  I. Sanz,et al.  Extrafollicular responses in humans and SLE , 2019, Immunological reviews.

[30]  Vito Adrian Cantu,et al.  PRINSEQ++, a multi-threaded tool for fast and efficient quality control and preprocessing of sequencing datasets , 2019 .

[31]  N. Baumgarth,et al.  The Multifaceted B Cell Response to Influenza Virus , 2019, The Journal of Immunology.

[32]  Christoph Hafemeister,et al.  Comprehensive integration of single cell data , 2018, bioRxiv.

[33]  F. Suter-Riniker,et al.  Effective chemical virus inactivation of patient serum compatible with accurate serodiagnosis of infections , 2018, Clinical Microbiology and Infection.

[34]  G. Gibson,et al.  Distinct Effector B Cells Induced by Unregulated Toll‐like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus , 2018, Immunity.

[35]  A. Chuansumrit,et al.  B cell subset alteration and the expression of tissue homing molecules in dengue infected patients , 2018, Journal of Biomedical Science.

[36]  Paul Hoffman,et al.  Integrating single-cell transcriptomic data across different conditions, technologies, and species , 2018, Nature Biotechnology.

[37]  T. Niewold,et al.  Type I interferon in rheumatic diseases , 2018, Nature Reviews Rheumatology.

[38]  Kamil Slowikowski,et al.  Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis , 2017, Nature.

[39]  H. Ueno.  T follicular helper cells in human autoimmunity. , 2016, Current opinion in immunology.

[40]  Steven H. Kleinstein,et al.  Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data , 2015, Bioinform..

[41]  Jay B. Varkey,et al.  Human Ebola virus infection results in substantial immune activation , 2015, Proceedings of the National Academy of Sciences.

[42]  Philip D. Hodgkin,et al.  The generation of antibody-secreting plasma cells , 2015, Nature Reviews Immunology.

[43]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[44]  Steven H. Kleinstein,et al.  Models of Somatic Hypermutation Targeting and Substitution Based on Synonymous Mutations from High-Throughput Immunoglobulin Sequencing Data , 2013, Front. Immunol..

[45]  Ning Ma,et al.  IgBLAST: an immunoglobulin variable domain sequence analysis tool , 2013, Nucleic Acids Res..

[46]  Y. Choi,et al.  CD9 is a novel marker for plasma cell precursors in human germinal centers. , 2013, Biochemical and biophysical research communications.

[47]  B. Pulendran,et al.  Rapid and Massive Virus-Specific Plasmablast Responses during Acute Dengue Virus Infection in Humans , 2012, Journal of Virology.

[48]  P. D. De Jager,et al.  The CD6 Multiple Sclerosis Susceptibility Allele Is Associated with Alterations in CD4+ T Cell Proliferation , 2011, The Journal of Immunology.

[49]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[50]  H. Ueno,et al.  Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. , 2011, Immunity.

[51]  P. Conigliaro,et al.  The type I IFN system in rheumatoid arthritis , 2010, Autoimmunity.

[52]  I. Henderson,et al.  Salmonella Induces a Switched Antibody Response without Germinal Centers That Impedes the Extracellular Spread of Infection1 , 2007, The Journal of Immunology.

[53]  Andreas Radbruch,et al.  Regulation of CXCR3 and CXCR4 expression during terminal differentiation of memory B cells into plasma cells. , 2005, Blood.

[54]  Marie-Paule Lefranc,et al.  IMGT , the international ImMunoGeneTics information system , 2003 .

[55]  E. Kunkel,et al.  Plasma-cell homing , 2003, Nature Reviews Immunology.

[56]  J. Kearney,et al.  CD9 Is a Unique Marker for Marginal Zone B Cells, B1 Cells, and Plasma Cells in Mice1 , 2002, The Journal of Immunology.

[57]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..